Breaking News: FDA Approves Treatment for pNET Patients

For the first time in nearly three decades, there is a new treatment for pancreatic neuroendocrine tumor patients!  The Food and Drug Administration (FDA) today announced its approval of Afinitor© for pNET patients.  This is a milestone for the carcinoid/NET community!

Read more about Novartis’ Afinitor. And CLICK HERE for further details.

Print Friendly, PDF & Email